Evidence map›Paper›PMID 40283445›Full record

ReviewJournal of clinical medicine2025

Charting the Pathways of Cardiometabolic Multimorbidity: A Systematic Review of Clinical Trajectories.

Ignatios Ioakeim-Skoufa, Rubén Ledesma-Calvo, Aida Moreno-Juste, Fátima Roque, Kerry Atkins, Miguel Ángel Hernández-Rodríguez, Mercedes Aza-Pascual-Salcedo, Francisca González-Rubio, Carmen Lasala-Aza, Óscar Esteban-Jiménez and 4 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ignatios Ioakeim-SkoufaDepartment of Drug Statistics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, 0213 Oslo, Norway.ORCID 0000-0002-6518-749X
Rubén Ledesma-CalvoDepartment of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Aida Moreno-JusteEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), Aragon Health Research Institute (IIS Aragón), Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0002-8819-3278
Fátima RoquePortuguese Society of Health Care Pharmacists (SPFCS), 3000-316 Coimbra, Portugal.ORCID 0000-0003-0169-3788
Kerry AtkinsDrug Utilisation Section, Technology Assessment and Access Division, Australian Government Department of Health and Aged Care, Canberra, ACT 2606, Australia.
Miguel Ángel Hernández-RodríguezDrug Utilisation Work Group, Spanish Society of Family and Community Medicine (semFYC), 08009 Barcelona, Spain.ORCID 0000-0001-7545-8057
Mercedes Aza-Pascual-SalcedoEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), Aragon Health Research Institute (IIS Aragón), Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0002-8937-5559
Francisca González-RubioEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), Aragon Health Research Institute (IIS Aragón), Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0001-5939-4436
Carmen Lasala-AzaPharmacy Service, Virgen de la Victoria University Hospital, 29010 Malaga, Spain.ORCID 0000-0002-2178-9130
Óscar Esteban-JiménezDrug Utilisation Work Group, Spanish Society of Family and Community Medicine (semFYC), 08009 Barcelona, Spain.
Ana Avedillo-SalasDepartment of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0003-2153-0417
Celeste Cebollada-HerreraDepartment of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Antonio Gimeno-MiguelEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), Aragon Health Research Institute (IIS Aragón), Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0002-5440-1710
Jorge Vicente-RomeroDepartment of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0003-4629-6743

Funding

Carlos III Institute of Health RD21/0016/0019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiometabolic diseaseschronic diseasecluster analysiscomorbiditydisease progressionlongitudinal studiesmortalitymultimorbidityquality of liferisk factors

Identifiers

PMID40283445
PMCPMC12028097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.